CNS Amyloid- , Soluble APP- and - Kinetics during BACE Inhibition
Randall J. Bateman(Washington University in St. Louis), Kristin R. Wildsmith(Eisai (United States)), Bruce W. Patterson(Washington University in St. Louis), Parker D. Mathers(Center for Agricultural Resources Research), Declan M. McLoughlin(St. Patrick's Hospital), David B. Gilberto(Center for Agricultural Resources Research), Daniel Holder(University of California San Diego), Matthew Kennedy(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kevin E. Yarasheski(Washington University in St. Louis), Maria S. Michener(United States Military Academy), Yuriy Pyatkivskyy, A. W. STAMFORD(Institute of Medicinal Plant Development), Robert Chott(Washington University in St. Louis), Christina Lennox(Center for Agricultural Resources Research), Guoxin Wu(Dalian University of Technology), Mary J. Savage(Merck & Co., Inc., Rahway, NJ, USA (United States)), Thomas P. Kasten(Monsanto (United States)), Vladimir Ovod, Mandy Dancho(Center for Agricultural Resources Research), Benn E. Smith(Center for Agricultural Resources Research)
Cited by 40
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Alzheimer's disease
|Nature Reviews Disease Primers|2015|1.8k